T 1122/17 of 06.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T112217.20210406
- Date of decision
- 6 April 2021
- Case number
- T 1122/17
- Petition for review of
- -
- Application number
- 10737870.5
- IPC class
- C07D 413/12C07D 471/04A61K 31/553C07D 487/04C07D 265/30C07D 417/12A61P 9/00A61P 25/00A61K 31/5377
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- OXAZINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
- Applicant name
- Novartis AG
- Opponent name
- Janssen Pharmaceutica NV
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Agreement to text withdrawn by patent proprietor - appeal dismissed
- Catchword
- -
- Cited cases
- T 0454/15
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.